Dr. Scott M. Rocklage holds a Bachelor of Science degree in Chemistry from the University of California. His impressive educational background is capped with a Doctor of Philosophy (Ph. D) degree in Chemistry from Massachusetts Institute of Technology.
His successful career in science began in Massachusetts Institute of Technology where he met and worked with Richard Schrock who helped Dr. Scott commence his research. Dr. Scott has over thirty years experience in healthcare management that integrates with his solid science background hence a distinguished professional in healthcare and research.
Basing on his extensive experience and impressive work history, Dr. Scott was appointed as a managing partner of 5AM Ventures in 2004. This was after joining the company a year earlier. Even at 61 years old, Dr. Scott still serves in various companies.
Currently, he is the chairman of the Boards of Achaogen, Semprus, and Relypsa. In addition to this, he sits on the board of associates of Whitehead Institute, WaveRx, Variation, Pulmatrix, Cidara Therapeutics, Kinestral, Epirus, and Renovia. Previous achievements and milestones in his professional life attribute to the numerous affiliations in healthcare centers.
Before joining 5AM Ventures, Dr. Scott served as the chairman and CEO at Cubist Pharmaceuticals as well as the CEO of Nycomed Salutar. Besides, he held influential leadership positions in Catalytica and Salutar, Novira, as well as executive positions at EntreMed and Amgen.
Achievements and broad network of Dr. Scott cannot be overemphasized. He has significantly contributed to growth and revolution of healthcare management by involving entrepreneurs in the industry. Read more: Scott Rocklage | Ideamesch and Scott Rocklage | Crunchbase
The FDA approval of Cubicin, Omniscan, and Teslascan as new drugs in the United States was mainly because of Dr. Scott’s impressive leadership and management techniques in the industry. His success in strategic leadership responsibility is expected for an individual with such level of education and extensive experience in healthcare management.
Moreover, Dr. Scott has published over 100 healthcare articles and books. His name is also on approximately 30 patents, either as the sole inventor or co-inventor.
The renowned doctor leads a team of experts at 5AM Ventures in invention and use of modern techniques to diagnose, prevent, and treat medical problems. The company encourages advancement in scientific methods concerning forms of treatment by supporting untraditional approaches.
Life science is the basis of 5AM ventures where Dr. Scott Rocklage works with business executives, scientists, and physicians to help develop ideas into drugs hence solving emerging and existing problems in the field of medicine.
Learn more about Scott Rocklage: